First published 10/3/2026, 7:38:15 PM · Last updated 10/3/2026, 7:38:15 PM

Baicalein reverse the methamphetamin-induced striatal dopaminergic neurotoxicity in mice

A Journal of Food and Drug Analysis article from Taiwan reports experimental results showing that the compound baicalein counteracts methamphetamine-related damage to dopamine-producing neurons in the mouse striatum. The source record identifies the publisher as JFDA and TFDA and is listed as a journal article.

Categories: science-and-space, science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 4/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study describes a potential neuroprotective effect of baicalein against methamphetamine-induced neuronal damage in an animal model.

Sources

Baicalein reverse the methamphetamin-induced striatal dopaminergic neurotoxicity in miceMetadata provided by Crossref. Usage terms

Report an issue